- Home
- MET vs CAH Comparison
MET vs CAH Comparison
Compare MET & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MET | CAH |
|---|---|---|
| Founded | 1863 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.1B | 51.2B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | MET | CAH |
|---|---|---|
| Price | $68.65 | $219.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $95.00 | ★ $230.45 |
| AVG Volume (30 Days) | ★ 3.6M | 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.25% | 0.95% |
| EPS Growth | N/A | ★ 86.96 |
| EPS | N/A | ★ 1.88 |
| Revenue | N/A | ★ $222,578,000,000.00 |
| Revenue This Year | $3.97 | $17.38 |
| Revenue Next Year | $4.48 | $9.00 |
| P/E Ratio | ★ $16.82 | $114.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $65.21 | $120.72 |
| 52 Week High | $83.85 | $233.60 |
Technical Indicators
Market Signals| Indicator | MET | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 30.22 | 49.74 |
| Support Level | N/A | $206.07 |
| Resistance Level | $81.60 | $231.90 |
| Average True Range (ATR) | 2.32 | 4.72 |
| MACD | -0.53 | -1.46 |
| Stochastic Oscillator | 6.18 | 32.02 |
Price Performance
Historical ComparisonAbout MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.